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Point-of-View
The long non-coding RNA Fendrr links epigenetic control mechanisms 
to gene regulatory networks in mammalian embryogenesis
Phillip Grote and Bernhard G Herrmann
Max Planck Institute for Molecular Genetics; Department Developmental Genetics; Berlin, Germany
Epigenetic control mechanisms deter-mine active and silenced regions of 
the genome. It is known that the Polycomb 
Repressive Complex 2 (PRC2) and the 
Trithorax group/Mixed lineage leukemia 
(TrxG/Mll) complex are able to set repres-
sive and active histone marks, respectively. 
Long non-coding RNAs (lncRNAs) can 
interact with either of these complexes 
and guide them to regulatory elements, 
thereby modifying the expression levels of 
target genes. The lncRNA Fendrr is tran-
siently expressed in lateral mesoderm of 
mid-gestational mouse embryos and was 
shown to interact with both PRC2 and 
TrxG/Mll complexes in vivo. Gene tar-
geting revealed that loss of Fendrr results 
in impaired differentiation of tissues 
derived from lateral mesoderm, the heart 
and the body wall, ultimately leading to 
embryonic death. Molecular data suggests 
that Fendrr acts via dsDNA/RNA triplex 
formation at target regulatory elements, 
and directly increases PRC2 occupancy 
at these sites. This, in turn, modifies the 
ratio of repressive to active marks, adjust-
ing the expression levels of Fendrr target 
genes in lateral mesoderm. We propose 
that Fendrr also mediates long-term epi-
genetic marks to define expression levels 
of its target genes within the descendants 
of lateral mesoderm cells. Here we discuss 
approaches for lncRNA gene knockouts 
in the mouse, and suggest a model how 
Fendrr and possibly other lncRNAs act 
during embryogenesis.
Introduction
The process of gastrulation generates 
the three germ layers: (neuro-) ectoderm, 
mesoderm, and (gut-) endoderm, which 
give rise to all organs of the body. In the 
mouse, this process takes place over six 
days and consecutively forms the anlage 
of the head, trunk, and tail. The lineage 
choice made by cells during gastrulation 
is the most crucial one for determining 
their fate and further differentiation of 
all of their descendants. Following the 
first lineage choice, cells can be recruited 
to various sub-lineages. For instance, 
the lateral mesoderm subdivides into the 
somatic and splanchnic mesoderm. In 
this manner, with each consecutive lin-
eage decision, cellular plasticity becomes 
more and more constrained. Thus, it is 
evident that the molecular activities con-
trolling the first lineage decision during 
gastrulation have the most impact on cell 
fate.
An example of an essential regula-
tor involved in early lineage decisions is 
the transcription factor Foxf1. The tar-
geted disruption of the Foxf1 gene pre-
vents the partition of lateral mesoderm 
into splanchnic and somatic mesoderm 
lineages, resulting in embryonic death.1 
Moreover, the Foxf1 mutant is haploin-
sufficient, i.e., embryos expressing Foxf1 
from a single active allele exhibit perina-
tal lethality with variable abnormalities, 
including lung defects. This underpins 
the crucial role of this transcription fac-
tor during embryonic development.2
Many other protein-coding genes, 
which play essential and specific roles dur-
ing embryonic development, have been 
described over the past two decades. The 
discovery of microRNAs (miRNAs) as 
essential regulators of developmental pro-
grams has shifted the focus toward genes 
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transcribed into non-coding RNA mol-
ecules.3–6 MiRNAs are a class of non-
coding RNAs, which are processed into 
single-stranded RNAs of ~22 nucleotides 
in length, and form functional units with 
the RNA-induced silencing complex 
(RISC). They are known to be involved 
in post-transcriptional control of gene 
expression. LncRNAs constitute a dis-
tinct class of RNA molecules, which are 
typically over 200 nucleotides in length, 
highly heterogeneous, and associated 
with a plethora of different functions, but 
in particular epigenetic gene control (for 
review, see refs. 7 and 8).
Recent data from the human 
ENCODE project identified 13 333 
genes encoding 22 631 transcripts in the 
human genome belonging to the lncRNA 
class (www.gencodegenes.org).9 They 
preferentially localize to the nucleus and, 
therefore, are thought to be involved in 
genome regulation.10 Although many of 
these lncRNAs contain short open read-
ing frames and can be found associated 
with ribosomes, the majority of them are 
assumed to be non-coding.11,12
The identification and functional 
analysis of lncRNA transcripts encoded 
by the murine Xist (Xi-specific tran-
script) locus within the X-inactivation 
center (XIC) first revealed the impor-
tance of nuclear lncRNAs in genome reg-
ulation and embryonic development.13,14 
The lncRNAs Xist and RepA, a PRC2 
binding lncRNA transcribed from the 
Xist locus, were shown to play a role in 
X-chromosome inactivation.15 Moreover, 
the PRC2 component Enhancer of Zeste 
Homolog 2 (EZH2) was found to bind 
thousands of lncRNAs, further support-
ing a functional link between lncRNAs 
and histone-modifying protein com-
plexes.16 Further importance of lncRNAs 
as factors regulating genome activity 
through histone-modifying complexes 
came from the discovery of HOTAIR, 
which is expressed from the HOXC 
locus and enhances PRC2 activity at the 
HOXD locus.17 HOTAIR binds to and 
might serve as a molecular scaffold for 
the histone-modifying complexes PRC2 
and LSD1/CoREST/REST.18 In addi-
tion, the lncRNAs HOTTIP, Mistral, 
and NeST have been shown to asso-
ciate with the TrxG/Mll component 
WDR5.19–21
The ability to survey the transcrip-
tional landscape through the technique of 
RNA-seq allows screening for lncRNAs, 
which are differentially expressed during 
embryogenesis. We analyzed six tissues 
from mid-gestational mouse embryos 
(embryonic day [E] 8.25) for the pres-
ence of lncRNAs, and identified several 
hundred which are expressed in a tissue-
restricted manner (unpublished). This 
data set provided the basis for determin-
ing whether lncRNAs are able to play an 
essential role in development.
Functional Analysis of lncRNAs 
in Embryonic Development
The functional analysis of numer-
ous embryonic control genes has shown 
that the expression pattern of essential 
regulators in the embryo is often highly 
restricted. Thus, we presumed that 
restricted expression may also serve as a 
useful criterion for selecting lncRNA genes 
for functional analyses. We analyzed a 
number of lncRNAs showing differential 
expression in the RNA-seq data in more 
detail by whole-mount in situ hybrid-
ization. One of these, Fendrr, showed a 
remarkably restricted and specific expres-
sion in the nascent lateral mesoderm. It 
is divergently transcribed from the Foxf1 
promoter and is co-expressed with Foxf1.22 
Since divergently transcribed long non-
coding/mRNA gene pairs are thought to 
be functionally linked and represent an 
intriguing gene class,23,24 we decided to 
proceed to a functional analysis of Fendrr 
in the mouse.
Most current studies on the function of 
lncRNAs involve RNAi or similar mecha-
nisms to reduce transcript levels.6,25–29 It 
is, however, important to note that tran-
scripts that localize to the nucleus are less 
susceptible to knockdown by RNAi. In 
addition, many lncRNAs exhibit a very 
low expression level.10,30 Hence, it can-
not be excluded that even a few residual 
transcripts per cell that escape knockdown 
might be functionally sufficient. Initially, 
we attempted the functional analysis of 
Fendrr by using an in vivo knockdown 
system, which we had previously applied 
to the inactivation of several protein-
coding genes.31 However, an shRNAmir 
construct expressing two different hair-
pins against Fendrr (best of six individu-
ally tested hairpins) achieved a maximal 
knockdown of only 60%. We observed 
no apparent phenotype in knockdown 
embryos up to embryonic day E18.0. 
Thus, 40% of the total Fendrr transcript 
was sufficient for embryonic development. 
This finding also holds true for many, if 
not most, transcription factors.
The gold standard for analyzing gene 
function in the mouse is gene targeting, 
resulting in a loss-of-function mutation. 
A number of approaches have been devel-
oped for targeting protein-coding genes, 
Figure 1. ChiRP (Chromatin isolation by RnA purification) analysis shows that Fendrr interacts with 
target promoters in embryonic stem cells differentiated in vitro. fourteen biotinylated oligonu-
cleotides tiling the Fendrr transcript were combined in even and odd numbered pools. (A) each 
oligo-pool specifically precipitated the Fendrr transcript. (B) At least one pool of tiling oligos co-
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however, non-coding genes provide fewer 
options since an uncharacterized lncRNA 
sequence does not reveal the nucleotide 
stretch that is crucial for its function. Nota-
bly, it has been shown that nucleotides 
within the first 300 bases of the HOTAIR 
lncRNA transcript interact with EZH2.18 
Thus, for a clear functional analysis of 
lncRNAs the complete transcript must 
be prevented from being expressed. One 
previously used option involves deletion 
of the complete gene.32,33 This approach 
is not ideal, since the deletion might also 
remove cis-acting regulatory sequences for 
neighboring genes.23,24,34 Another option 
is to integrate a strong transcriptional stop 
signal right at the start of the transcription 
unit. We consider this latter option supe-
rior, but it should be noted that possible 
alternative transcriptional start sites (TSS) 
downstream of the TSS that has been cho-
sen for stop-cassette integration must not 
be overlooked. Also, since the insertion of 
genetic elements such as transcriptional 
stop signals can alter the chromatin land-
scape and, thereby, influence gene regu-
lation at the site of insertion, it is crucial 
to rule out that the phenotype observed 
is due to a secondary effect. This can be 
done by a rescue experiment wherein the 
lncRNA transcript is expressed from a 
construct integrated randomly into the 
genome. If the phenotype is rescued it 
proves that the knockout phenotype was 
indeed caused by loss of the lncRNA tran-
script and, moreover, that the lncRNA 
acts in trans.
Two strong transcriptional stop signals 
have been previously used for gene knock-
out, a triple SV40 polyA signal and the 
chicken β-globin polyA signal.35,36 Both 
elements harbor an intron upstream of the 
polyadenylation signal that is presumed 
to increase their efficacy. Insertion of the 
triple SV40 polyA cassette into the first 
exon of Fendrr proved to be very efficient, 
but not absolutely transcriptionally tight. 
A residual transcript level of 0.1% was still 
detectable in Fendrr mutants following 
3´ SV40 pA insertion (data not shown). 
However, this residual activity was found 
to be insufficient for Fendrr function. Fen-
drr mutants presented with omphalocele 
and showed malfunctioning of the heart, 
which resulted in embryonic death by 
E13.75.22
To rescue the Fendrr-knockout pheno-
type, we integrated a mini-gene construct 
expressing the Fendrr transcript under 
control of the human ACTB promoter 
randomly into the genome of Fendrr-null 
ES cells. Ubiquitous expression of Fendrr 
at approximately 20% of its wild-type 
level was observed in embryos derived 
from the transgenic ES cells. This level 
of Fendrr transcript was not sufficient for 
a complete rescue of the knockout phe-
notype. For instance, though surviving 
embryos showed no omphalocele at E14.5 
(Fendrr null: 100% omphalocele), the 
survival rate only increased moderately 
(from 21% [n = 9] to 60% [n = 5]). This 
partial rescue is most likely due to low 
Fendrr expression in the lateral mesoderm, 
but we cannot exclude the possibility that 
ubiquitous ectopic expression of Fendrr in 
the embryo may have contributed to the 
observed lethality.
We reasoned that expressing Fendrr 
under control of its endogenous promoter, 
providing correct spatial and temporal 
control as well as correct expression lev-
els, would be more adequate for achieving 
rescue of the knockout phenotype. There-
fore, we randomly integrated a BAC (bac-
terial artificial chromosome) containing 
an intact Fendrr gene in the middle of a 
172194 bp region of the C57Bl/6J mouse 
genome, into Fendrr-null ES cells. The 
BAC clone was genetically modified by 
insertion of a Neomycin selection cassette 
into the translational start site of Foxf1. 
This inactivated Foxf1, thus avoiding an 
increase of Foxf1 activity, which might 
trigger unwanted effects in BAC trans-
genic embryos, while it left the Fendrr 
transcription unit on the BAC unchanged, 
and also allowed for antibiotic selection of 
ES clones, which had integrated the BAC. 
This construct faithfully reproduced the 
wild-type expression pattern of Fendrr, 
and produced approximately 50% of the 
Fendrr transcript level observed in wild-
type embryos, corresponding to expres-
sion of one allele.22 This construct rescued 
the Fendrr-null phenotype until E17.5 
illustrating that the Fendrr lncRNA acts in 
trans, and that loss of the Fendrr transcript 
is responsible for the lethal phenotype.
The rescue experiment was also neces-
sary as a test of the genetic integrity of the 
mutant ES cells that were used for embryo 
production via tetraploid complementa-
tion.37 One advantage of tetraploid com-
plementation over blastocyst injection for 
producing knockout mouse lines is the vast 
difference in the time required for obtain-
ing homozygous embryos. While the stan-
dard approach takes 8–12 mo, tetraploid 
complementation allows the production 
of virtually pure ES cell-derived homozy-
gous embryos directly from the genetically 
altered cells (consecutively mutated on 
both alleles, which takes around 2–3 mo). 
In a typical experiment, 8 to 12 geneti-
cally identical homozygous embryos can 
be obtained per mouse. Additional genetic 
manipulations, such as the introduction of 
a reporter, constructs for lineage tracing, 
rescue BAC, etc. can be performed in a 
reasonably short time frame. Importantly, 
the genetic background of the embryos 
produced for knockout and consecutive 
analyses can be kept virtually identical, 
which is highly desirable to avoid errors 
due to background effects. Therefore, the 
Figure 2. Fendrr anchors PRC2 to specific target sites. Schematic drawing illustrating binding of the 
Fendrr/PRC2 complex through a 40-nucleotide stretch (red) to specific recognition sequences in 
target promoters, e.g., that of Foxf1 and Pitx2, thus increasing PRC2 occupancy and H3K27 trimeth-
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starting ES cell line does not need to be 
derived from an inbred strain.
Mode of Fendrr Action in 
Embryonic Development
Fendrr mutant embryos appear nor-
mal until E12.5, but by E14.5 most are 
dead. Both sub-lineages of the lateral 
plate mesoderm are affected: the heart, 
a derivative of the splanchnic mesoderm, 
and the ventral body wall, a product of the 
somatic mesoderm. The heart progenitors 
express Fendrr transiently at E6.5–7.0, 
and the progenitors of the ventral body 
wall at around E9.5 of development. We 
showed that proliferation of cardiomyo-
cytes is impaired in Fendrr mutants, but 
not before E12.5.18 Thus, there is a delay of 
6 d between the time of Fendrr expression 
in wild-type embryos and malfunction-
ing of the tissue derived from Fendrr-null 
cells in the mutant. How can this delay 
be explained? The molecular analysis 
provided some important hints toward 
answering this question.
Analogous to the human FENDRR 
(previously FOXF1-AS1) transcript, 
mouse Fendrr binds to the PRC2 com-
plex.22,38 We showed that the occupancy of 
PRC2 was severely reduced at three puta-
tive target promoters in the mutant, which 
led to decreased trimethylation of lysine 
27 on histone 3 (H3K27me3), the foot-
print of PRC2.22 For two of these targets, 
Foxf1 and Pitx2, we provided evidence 
that Fendrr interacts directly with the pro-
moter DNA. Using an in silico approach, 
we identified a 40-nucleotide stretch of 
the Fendrr RNA, which is able to pre-
cipitate the Foxf1 and Pitx2 promoters in 
vitro.22 This interaction is not destroyed 
by RNaseH treatment, excluding hetero-
duplex formation as a binding mechanism 
between Fendrr and the promoter DNA. 
The 40-base binding sequence also closely 
resembles a purine-pyrimidine motif that 
has been previously shown to favor triplex 
formation.39,40
We confirmed by ChIRP (Chromatin 
isolation by RNA purification) analysis41 
that interaction of Fendrr with the Foxf1 
and Pitx2 promoters exists in a cellular 
context. For this we differentiated mouse 
ES cells to mesoderm in vitro for 4 d to 
reach peak expression of endogenous Fen-
drr. We then precipitated Fendrr RNA 
from cellular extracts with two pools of 
tiling oligonucleotides complementary to 
Fendrr. We found that Foxf1 and Pitx2 
promoter DNA co-precipitated with at 
least one of the pools (Fig. 1).
Taken together, these data suggest that 
Fendrr binds to target dsDNA sequences 
via formation of a dsDNA:RNA triplex 
structure. Fendrr binds to specific sites 
Figure 3. Model of immediate and long-term effects of Fendrr acting via PRC2 on epigenetic modification and gene expression. the ratio of repressive 
H3K27me3 (blue) to active H3K4me3 (red) marks determines the level of gene expression. Histone marks set in the lateral mesoderm are maintained in 
the descendants of these cells until they are modified by other site-specific regulators resulting, for instance, in an increase in the repressive or a reduc-
tion in the active marks within cardiac mesoderm (indicated by arrows). in the case of Foxf1, this leads to a dominating repressive mark and silencing of 
the gene in wild-type cardiac mesoderm. in Fendrr mutant cells, anchoring of PRC2 to the Foxf1 promoter fails, thus skewing the H3K27me3/H3K4me3 
ratio and leading to an increased Foxf1 expression level. the subsequent histone modifications which normally take place in cardiac mesoderm are not 
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at target promoters as well as to PRC2. 
This increases PRC2 occupancy at the 
promoters, allowing for enhanced H3K27 
trimethylation. Therefore, at least in the 
context of PRC2 binding, Fendrr acts as an 
anchor to promote repressive H3K27 tri-
methylation at target promoters (Fig. 2).
We were able to show that Fendrr 
also interacts with the TrxG/Mll com-
ponent WDR5. TrxG/Mll sets active 
marks by methylating lysine 4 on histone 
3 (H3K4me3). We found that all genes 
showing higher mRNA expression in the 
Fendrr mutant in our analysis also dis-
played increased H3K4me3 levels at their 
promoters. However, WDR5 occupancy 
was not enhanced in parallel, suggesting 
an indirect effect of Fendrr loss on H3K4 
trimethylation at these promoters. Indeed, 
the H3K4me3 active mark can be set by 
numerous methyl-transferase-containing 
complexes. Besides the MLL family of 
methyl-transferases from the TrxG/Mll 
complexes, SETD1A, SETD1B, SETD7, 
SMYD1/2/3, and ASH1L have also been 
shown to methylate H3K4.42–47 Moreover, 
WDR5 has also been found as a compo-
nent of the histone acetylating complexes 
NSL/MSL1v and ATAC.48,49 Hence, at 
present it cannot be absolutely excluded 
that Fendrr might interact with any of 
these latter complexes involving WDR5.
The increase in target gene expres-
sion observed in Fendrr mutants is rather 
mild—on the order of 30–40% over the 
wild-type level. Is it conceivable that the 
altered expression of numerous (presumed) 
Fendrr target genes together causes suffi-
cient cellular imbalance to lead to a phe-
notype? Some transcriptional regulators 
exhibit haploinsufficiency phenotypes, 
demonstrating that expression of a single 
allele can be insufficient for proper embry-
onic development, and the Fendrr targets 
Foxf1 and Pitx2 both belong to this group 
of genes.2,50 However, can a mild overex-
pression also cause impaired cellular func-
tion, or is the Fendrr phenotype due to a 
different mechanism?
Foxf1 is completely silenced in the car-
diac tissue of E12.5 wild-type embryos, 
but is ectopically expressed (at a low 
level) in the cardiac tissue of E12.5 Fendrr 
mutants.22 This finding, combined with 
the delay between Fendrr expression in the 
lateral plate mesoderm and the onset of 
heart dysfunction in Fendrr mutants, sug-
gests a long-term effect of Fendrr action, a 
characteristic of epigenetic control mecha-
nisms. In the mutants, failure to increase 
the level of repressive H3K27me3 marks, 
in combination with an increase in the 
active H3K4me3 mark at the Foxf1 pro-
moter in the lateral mesoderm apparently 
affects the ability of descendants of these 
cells in the cardiac mesoderm to silence 
Foxf1. It is conceivable that, in wild-type 
cells, an increase of the H3K27me3/
H3K4me3 ratio mediated by Fendrr at 
target promoters in nascent lateral meso-
derm at a later stage of cardiac mesoderm 
differentiation is followed by a reduc-
tion of the active or an enhancement of 
the repressive mark, leading to a further 
increase of the H3K27me3/H3K4me3 
ratio followed by gene silencing (Fig. 3). 
Since the H3K27me3/H3K4me3 ratio 
in lateral mesoderm of Fendrr mutants 
is reduced in favor of the active mark, a 
reduction of the resulting high H3K4me3 
level or increase of the repressive marks in 
cardiac mesoderm might not be sufficient 
anymore to permit silencing of the Foxf1 
promoter (Fig. 3). In this manner, setting 
and removal of active and repressive marks 
mediated by promoter-specific factors at 
consecutive stages of cell differentiation 
might control the activities of many genes, 
including important regulatory proteins, 
in a differential manner. Consecutive epi-
genetic modifications at particular pro-
moters might be separated by hours or 
days and, thus, changes set early in a cell 
lineage may become effective much later 
in descendants of that lineage. This mode-
of-action is quite different from the way 
transcription factors work, where a loss 
usually becomes effective right away in the 
very cells they are expressed in.
In summary, we propose that Fendrr 
functions in the lateral mesoderm via 
epigenetic modification of regulatory ele-
ments, thereby adjusting the expression 
level of target genes in this tissue and set-
ting long-term marks, which allow for the 
proper control of Fendrr target genes in 
the descendants of lateral mesoderm cells.
In addition to its role in embryogenesis, 
the human FENDRR gene has been found 
to be expressed in the lung, and to be 
associated with a lethal lung developmen-
tal disorder called ACD/MPV (alveolar 
capillary dysplasia with misalignment of 
pulmonary veins).51 In one ACD/MPV 
case (#41.1) an 11 kb deletion removed the 
distal portion of the FOXF1 promoter and 
a portion of FENDRR (FOXF1-AS1).34 
Notably, knockdown of FENDRR by 
siRNA in Human Pulmonary Microvas-
cular Endothelial Cells (HPMEC) caused 
a weak increase of FOXF1 transcription, 
supporting the finding that FENDRR acts 
as transcriptional repressor.34
Perspectives
Fendrr is one of the first lncRNAs that 
has been shown to play an essential role in 
mammalian embryogenesis. Our prelimi-
nary data obtained by deep sequencing of 
the transcriptomes of six tissues dissected 
from E8.25 mouse embryos revealed 
several hundred differentially expressed 
lncRNAs, and many more are expected 
to arise from high-resolution RNA-seq 
analyses of different developmental stages. 
Current available information suggests 
that lncRNAs play a pivotal role in epi-
genetic control mechanisms acting in cells 
and on cell lineages. However, detailed 
functional analyses of many such genes 
are needed in order to derive a clearer pic-
ture of the roles of lncRNAs in epigenetic 
regulatory networks.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
We thank Tracie Pennimpede and Arica 
Beisaw for comments on the manuscript.
References
1. Mahlapuu M, Ormestad M, Enerbäck S, Carlsson P. 
The forkhead transcription factor Foxf1 is required 
for differentiation of extra-embryonic and lateral 
plate mesoderm. Development 2001; 128:155-66; 
PMID:11124112
2. Mahlapuu M, Enerbäck S, Carlsson P. 
Haploinsufficiency of the forkhead gene Foxf1, a 
target for sonic hedgehog signaling, causes lung 
and foregut malformations. Development 2001; 
128:2397-406; PMID:11493558
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans 
heterochronic gene lin-4 encodes small RNAs 
with antisense complementarity to lin-14. Cell 
1993; 75:843-54; PMID:8252621; http://dx.doi.
org/10.1016/0092-8674(93)90529-Y
4. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, 
Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. 
The 21-nucleotide let-7 RNA regulates developmen-

























1584 RnA Biology Volume 10 issue 10
5. Lee RC, Ambros V. An extensive class of small RNAs 
in Caenorhabditis elegans. Science 2001; 294:862-
4; http://dx.doi.org/10.1126/science.1065329; 
PMID:11679672
6. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs 
modulate hematopoietic lineage differentiation. 
Science 2004; 303:83-6; http://dx.doi.org/10.1126/
science.1091903; PMID:14657504
7. Lee JT. Epigenetic regulation by long noncoding 
RNAs. Science 2012; 338:1435-9; http://dx.doi.
org/10.1126/science.1231776; PMID:23239728
8. Rinn JL, Chang HY. Genome regulation by long 
noncoding RNAs. Annu Rev Biochem 2012; 
81:145-66; http://dx.doi.org/10.1146/annurev-bio-
chem-051410-092902; PMID:22663078
9. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali 
S, Tilgner H, Guernec G, Martin D, Merkel A, 
Knowles DG, et al. The GENCODE v7 catalog of 
human long noncoding RNAs: analysis of their 
gene structure, evolution, and expression. Genome 
Res 2012; 22:1775-89; http://dx.doi.org/10.1101/
gr.132159.111; PMID:22955988
10. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann 
T, Mortazavi A, Tanzer A, Lagarde J, Lin W, 
Schlesinger F, et al. Landscape of transcription in 
human cells. Nature 2012; 489:101-8; http://dx.doi.
org/10.1038/nature11233; PMID:22955620
11. Ingolia NT, Lareau LF, Weissman JS. Ribosome 
profiling of mouse embryonic stem cells reveals the 
complexity and dynamics of mammalian proteomes. 
Cell 2011; 147:789-802; http://dx.doi.org/10.1016/j.
cell.2011.10.002; PMID:22056041
12. Guttman M, Russell P, Ingolia NT, Weissman JS, 
Lander ES. Ribosome Profiling Provides Evidence 
that Large Noncoding RNAs Do Not Encode 
Proteins. Cell 2013; 154:240-51; http://dx.doi.
org/10.1016/j.cell.2013.06.009; PMID:23810193
13. Brown CJ, Hendrich BD, Rupert JL, Lafrenière 
RG, Xing Y, Lawrence J, Willard HF. The 
human XIST gene: analysis of a 17 kb inactive 
X-specific RNA that contains conserved repeats 
and is highly localized within the nucleus. Cell 
1992; 71:527-42; PMID:1423611; http://dx.doi.
org/10.1016/0092-8674(92)90520-M
14. Brockdorff N, Ashworth A, Kay GF, McCabe VM, 
Norris DP, Cooper PJ, Swift S, Rastan S. The product 
of the mouse Xist gene is a 15 kb inactive X-specific 
transcript containing no conserved ORF and located 
in the nucleus. Cell 1992; 71:515-26; PMID:1423610; 
http://dx.doi.org/10.1016/0092-8674(92)90519-I
15. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb 
proteins targeted by a short repeat RNA to the 
mouse X chromosome. Science 2008; 322:750-
6; http://dx.doi.org/10.1126/science.1163045; 
PMID:18974356
16. Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, 
Sarma K, Song JJ, Kingston RE, Borowsky M, Lee 
JT. Genome-wide identification of polycomb-associ-
ated RNAs by RIP-seq. Mol Cell 2010; 40:939-53; 
http://dx.doi.org/10.1016/j.molcel.2010.12.011; 
PMID:21172659
17. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, 
Brugmann SA, Goodnough LH, Helms JA, Farnham 
PJ, Segal E, et al. Functional demarcation of active 
and silent chromatin domains in human HOX loci 
by noncoding RNAs. Cell 2007; 129:1311-23; 
PMID:17604720; http://dx.doi.org/10.1016/j.
cell.2007.05.022
18. Tsai MC, Manor O, Wan Y, Mosammaparast N, 
Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long 
noncoding RNA as modular scaffold of histone 
modification complexes. Science 2010; 329:689-
93; PMID:20616235; http://dx.doi.org/10.1126/
science.1192002
19. Wang KC, Yang YW, Liu B, Sanyal A, Corces-
Zimmerman R, Chen Y, Lajoie BR, Protacio A, 
Flynn RA, Gupta RA, et al. A long noncoding 
RNA maintains active chromatin to coordinate 
homeotic gene expression. Nature 2011; 472:120-
4; PMID:21423168; http://dx.doi.org/10.1038/
nature09819
20. Bertani S, Sauer S, Bolotin E, Sauer F. The noncoding 
RNA Mistral activates Hoxa6 and Hoxa7 expression 
and stem cell differentiation by recruiting MLL1 to 
chromatin. Mol Cell 2011; 43:1040-6; http://dx.doi.
org/10.1016/j.molcel.2011.08.019; PMID:21925392
21. Gomez JA, Wapinski OL, Yang YW, Bureau JF, 
Gopinath S, Monack DM, Chang HY, Brahic M, 
Kirkegaard K. The NeST long ncRNA controls 
microbial susceptibility and epigenetic activation 
of the interferon-γ locus. Cell 2013; 152:743-54; 
PMID:23415224; http://dx.doi.org/10.1016/j.
cell.2013.01.015
22. Grote P, Wittler L, Hendrix D, Koch F, Währisch S, 
Beisaw A, Macura K, Bläss G, Kellis M, Werber M, et 
al. The tissue-specific lncRNA Fendrr is an essential 
regulator of heart and body wall development in the 
mouse. Dev Cell 2013; 24:206-14; PMID:23369715; 
http://dx.doi.org/10.1016/j.devcel.2012.12.012
23. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-
Vega B, Regev A, Rinn JL. Integrative annotation 
of human large intergenic noncoding RNAs reveals 
global properties and specific subclasses. Genes Dev 
2011; 25:1915-27; PMID:21890647 ; http://dx.doi.
org/10.1101/gad.17446611
24. Sigova AA, Mullen AC, Molinie B, Gupta S, Orlando 
DA, Guenther MG, Almada AE, Lin C, Sharp PA, 
Giallourakis CC, et al. Divergent transcription of 
long noncoding RNA/mRNA gene pairs in embry-
onic stem cells. Proc Natl Acad Sci U S A 2013; 
110:2876-81; PMID:23382218; http://dx.doi.
org/10.1073/pnas.1221904110
25. Sun L, Goff LA, Trapnell C, Alexander R, Lo KA, 
Hacisuleyman E, Sauvageau M, Tazon-Vega B, Kelley 
DR, Hendrickson DG, et al. Long noncoding RNAs 
regulate adipogenesis. Proc Natl Acad Sci U S A 
2013; 110:3387-92; PMID:23401553; http://dx.doi.
org/10.1073/pnas.1222643110
26. Klattenhoff CA, Scheuermann JC, Surface LE, 
Bradley RK, Fields PA, Steinhauser ML, Ding H, 
Butty VL, Torrey L, Haas S, et al. Braveheart, a 
long noncoding RNA required for cardiovascu-
lar lineage commitment. Cell 2013; 152:570-83; 
PMID:23352431; http://dx.doi.org/10.1016/j.
cell.2013.01.003
27. Kretz M, Siprashvili Z, Chu C, Webster DE, 
Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, 
Chow J, et al. Control of somatic tissue differentia-
tion by the long non-coding RNA TINCR. Nature 
2013; 493:231-5; PMID:23201690; http://dx.doi.
org/10.1038/nature11661
28. Guttman M, Donaghey J, Carey BW, Garber M, 
Grenier JK, Munson G, Young G, Lucas AB, Ach 
R, Bruhn L, et al. lincRNAs act in the circuitry 
controlling pluripotency and differentiation. Nature 
2011; 477:295-300; PMID:21874018; http://dx.doi.
org/10.1038/nature10398
29. Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. 
Conserved function of lincRNAs in vertebrate embry-
onic development despite rapid sequence evolution. 
Cell 2011; 147:1537-50; http://dx.doi.org/10.1016/j.
cell.2011.11.055; PMID:22196729
30. Ravasi T, Suzuki H, Pang KC, Katayama S, Furuno 
M, Okunishi R, Fukuda S, Ru K, Frith MC, Gongora 
MM, et al. Experimental validation of the regulated 
expression of large numbers of non-coding RNAs 
from the mouse genome. Genome Res 2006; 16:11-
9; PMID:16344565; http://dx.doi.org/10.1101/
gr.4200206
31. Vidigal JA, Morkel M, Wittler L, Brouwer-Lehmitz 
A, Grote P, Macura K, Herrmann BG. An induc-
ible RNA interference system for the functional dis-
section of mouse embryogenesis. Nucleic Acids Res 
2010; 38:e122; PMID:20350929 ; http://dx.doi.
org/10.1093/nar/gkq199
32. Eißmann M, Gutschner T, Hämmerle M, Günther S, 
Caudron-Herger M, Groß M, Schirmacher P, Rippe 
K, Braun T, Zörnig M, et al. Loss of the abundant 
nuclear non-coding RNA MALAT1 is compatible 
with life and development. RNA Biol 2012; 9:1076-
87; PMID:22858678
33. Jones BK, Levorse JM, Tilghman SM. Igf2 imprint-
ing does not require its own DNA methylation or H19 
RNA. Genes Dev 1998; 12:2200-7; PMID:9679064; 
http://dx.doi.org/10.1101/gad.12.14.2200
34. Szafranski P, Dharmadhikari AV, Brosens E, 
Gurha P, Kolodziejska KE, Zhishuo O, Dittwald P, 
Majewski T, Mohan KN, Chen B, et al. Small non-
coding differentially methylated copy-number vari-
ants, including lncRNA genes, cause a lethal lung 
developmental disorder. Genome Res 2013; 23:23-
33; PMID:23034409; http://dx.doi.org/10.1101/
gr.141887.112
35. Lobe CG, Koop KE, Kreppner W, Lomeli H, 
Gertsenstein M, Nagy A. Z/AP, a double reporter 
for cre-mediated recombination. Dev Biol 
1999; 208:281-92; http://dx.doi.org/10.1006/
dbio.1999.9209; PMID:10191045
36. Sleutels F, Barlow DP. Investigation of elements suf-
ficient to imprint the mouse Air promoter. Mol Cell 
Biol 2001; 21:5008-17; http://dx.doi.org/10.1128/
MCB.21.15.5008-5017.2001; PMID:11438657
37. Gertsenstein M. Tetraploid Complementation 
Assay. 1st Edition. (Pease S, Saunders TL, eds.). 
Berlin, Heidelberg: Springer Berlin Heidelberg; 
2011:357–375. doi:10.1007/978-3-642-20792-1.
38. Khalil AM, Guttman M, Huarte M, Garber M, Raj 
A, Rivea Morales D, Thomas K, Presser A, Bernstein 
BE, van Oudenaarden A, et al. Many human large 
intergenic noncoding RNAs associate with chro-
matin-modifying complexes and affect gene expres-
sion. Proc Natl Acad Sci U S A 2009; 106:11667-72; 
PMID:19571010; http://dx.doi.org/10.1073/
pnas.0904715106
39. Buske FA, Bauer DC, Mattick JS, Bailey TL. 
Triplexator: detecting nucleic acid triple helices 
in genomic and transcriptomic data. Genome Res 
2012; 22:1372-81; PMID:22550012; http://dx.doi.
org/10.1101/gr.130237.111
40. Morgan AR, Wells RD. Specificity of the three-
stranded complex formation between dou-
ble-stranded DNA and single-stranded RNA 
containing repeating nucleotide sequences. J Mol 
Biol 1968; 37:63-80; PMID:5760495; http://dx.doi.
org/10.1016/0022-2836(68)90073-9
41. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. 
Genomic maps of long noncoding RNA occupancy 
reveal principles of RNA-chromatin interactions. Mol 
Cell 2011; 44:667-78; http://dx.doi.org/10.1016/j.
molcel.2011.08.027; PMID:21963238
42. Lee J-S, Smith E, Shilatifard A. The language of his-
tone crosstalk. Cell 2010; 142:682-5; http://dx.doi.
org/10.1016/j.cell.2010.08.011; PMID:20813257
43. Abu-Farha M, Lambert JP, Al-Madhoun AS, Elisma 
F, Skerjanc IS, Figeys D. The tale of two domains: 
proteomics and genomics analysis of SMYD2, a 
new histone methyltransferase. Mol Cell Proteomics 
2008; 7:560-72; PMID:18065756; http://dx.doi.
org/10.1074/mcp.M700271-MCP200
44. Gregory GD, Vakoc CR, Rozovskaia T, Zheng 
X, Patel S, Nakamura T, Canaani E, Blobel GA. 
Mammalian ASH1L is a histone methyltransferase 
that occupies the transcribed region of active genes. 
























www.landesbioscience.com RnA Biology 1585
45. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva 
FP, Li M, Yagyu R, Nakamura Y. SMYD3 encodes 
a histone methyltransferase involved in the prolif-
eration of cancer cells. Nat Cell Biol 2004; 6:731-
40; PMID:15235609; http://dx.doi.org/10.1038/
ncb1151
46. Tan X, Rotllant J, Li H, De Deyne P, Du SJ, SmyD1, 
a histone methyltransferase, is required for myofibril 
organization and muscle contraction in zebrafish 
embryos. Proc Natl Acad Sci U S A 2006; 103:2713-
8; http://dx.doi.org/10.1073/pnas.0509503103; 
PMID:16477022
47. Wang H, Cao R, Xia L, Erdjument-Bromage H, 
Borchers C, Tempst P, Zhang Y. Purification and 
functional characterization of a histone H3-lysine 
4-specific methyltransferase. Mol Cell 2001; 8:1207-
17; PMID:11779497; http://dx.doi.org/10.1016/
S1097-2765(01)00405-1
48. Li X, Wu L, Corsa CAS, Kunkel S, Dou Y. Two 
mammalian MOF complexes regulate transcrip-
tion activation by distinct mechanisms. Mol Cell 
2009; 36:290-301; http://dx.doi.org/10.1016/j.mol-
cel.2009.07.031; PMID:19854137
49. Wang Y-L, Faiola F, Xu M, Pan S, Martinez E. 
Human ATAC Is a GCN5/PCAF-containing acety-
lase complex with a novel NC2-like histone fold mod-
ule that interacts with the TATA-binding protein. 
J Biol Chem 2008; 283:33808-15; http://dx.doi.
org/10.1074/jbc.M806936200; PMID:18838386
50. Liu W, Selever J, Lu M-F, Martin JF. Genetic dissec-
tion of Pitx2 in craniofacial development uncovers 
new functions in branchial arch morphogenesis, late 
aspects of tooth morphogenesis and cell migration. 
Development 2003; 130:6375-85; http://dx.doi.
org/10.1242/dev.00849; PMID:14623826
51. Stankiewicz P, Sen P, Bhatt SS, Storer M, Xia Z, 
Bejjani BA, Ou Z, Wiszniewska J, Driscoll DJ, 
Maisenbacher MK, et al. Genomic and genic dele-
tions of the FOX gene cluster on 16q24.1 and inac-
tivating mutations of FOXF1 cause alveolar capillary 
dysplasia and other malformations. Am J Hum Genet 
2009; 84:780-91; PMID:19500772; http://dx.doi.
org/10.1016/j.ajhg.2009.05.005
